NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading TA: Ethereum is Showing Early Signs of Fresh Rally, But 100 SMA is the Key.